bid/ask 0.475 / 0.477
servu$
servu$
Top-News
Neuester,
zuletzt geles. Beitrag
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter
... 147 148 150 151 ...
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter ... 147 148 150 151 ...
sunwin wird laufen
Beiträge:
36.005
Zugriffe: 7.940.903 / Heute: 310
Zugriffe: 7.940.903 / Heute: 310
|
Werbung
Entdecke die beliebtesten ETFs von SPDR
Block von 55.000 zu 0,35 verkauft in Frankfurt ...kurz danach 36700 zu 0,35
"...
Sunwin International Neutraceuticals to Aggressively Pursue Opportunities in Europe After the European Commission's Recent Regulatory Approval of Stevia
QUFU, China, Nov. 15, 2011 /PRNewswire via COMTEX/ -- Sunwin International Neutraceuticals, Inc. (OTC.BB: SUWN), one of the top global providers of high quality Stevia extracts including Rebaudioside A 98, announced today that management intends to aggressively pursue opportunities in Europe after the European Commission's ("EC's")recent approval of Stevia for use in the food and beverage industry.
In May of 2011 Sunwin announced a collaboration with two major companies in the flavouring and sweetener industry, operating in Europe as well as many other parts of the globe, to introduce a wide range of all natural, low calorie and no calorie sweetening solutions that contain Sunwin Stevia(TM). The EC decision opens the door to a vast potential market for consumers seeking natural low calorie sweetening alternatives. Management intends to work aggressively to open distribution channels in the EU in the coming quarters to expand its Stevia sales.
The Stevia rebaundiana plant is used to produce zero-calorie steviol glycosides, which are up to 300 times sweeter than sucrose. This approval by the EC is a significant milestone for the Stevia industry. While the European Food Safety Authority (EFSA) gave a positive safety opinion on steviol glycosides in April 2010, in line with the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which approves the use of steviol glycosides at 95% purity or above, suppliers of Stevia had to wait for formal EC approval of steviol glycosides before entering the market.
Commenting on the EC's decision, Chairman Laiwang Zhang stated, "We are extremely pleased that the EC has given the regulatory go ahead for Stevia to be used in the EU food and beverage industry. Europe represents a vast market and we intend to work aggressively to establish European distribution of our Stevia products and work with industry leaders to develop unique products to address the needs of today's consumer seeking healthy, all natural, low calorie sweeteners."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. engages in the areas of essential traditional Chinese medicine and zero calorie natural sweeteners (Sunwin Stevia(TM) Extracts). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit www.sunwininternational.com.
Contact:
Lillian WongU.S. Representative 954-363-7333 ir@sunwininternational.com
Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance and expectations regarding revenues, net income and earnings.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2011.
SOURCE Sunwin International Neutraceuticals, Inc.
www.prnewswire.com
Copyright (C) 2011 PR Newswire. All rights reserved
..."
Sunwin International Neutraceuticals to Aggressively Pursue Opportunities in Europe After the European Commission's Recent Regulatory Approval of Stevia
QUFU, China, Nov. 15, 2011 /PRNewswire via COMTEX/ -- Sunwin International Neutraceuticals, Inc. (OTC.BB: SUWN), one of the top global providers of high quality Stevia extracts including Rebaudioside A 98, announced today that management intends to aggressively pursue opportunities in Europe after the European Commission's ("EC's")recent approval of Stevia for use in the food and beverage industry.
In May of 2011 Sunwin announced a collaboration with two major companies in the flavouring and sweetener industry, operating in Europe as well as many other parts of the globe, to introduce a wide range of all natural, low calorie and no calorie sweetening solutions that contain Sunwin Stevia(TM). The EC decision opens the door to a vast potential market for consumers seeking natural low calorie sweetening alternatives. Management intends to work aggressively to open distribution channels in the EU in the coming quarters to expand its Stevia sales.
The Stevia rebaundiana plant is used to produce zero-calorie steviol glycosides, which are up to 300 times sweeter than sucrose. This approval by the EC is a significant milestone for the Stevia industry. While the European Food Safety Authority (EFSA) gave a positive safety opinion on steviol glycosides in April 2010, in line with the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which approves the use of steviol glycosides at 95% purity or above, suppliers of Stevia had to wait for formal EC approval of steviol glycosides before entering the market.
Commenting on the EC's decision, Chairman Laiwang Zhang stated, "We are extremely pleased that the EC has given the regulatory go ahead for Stevia to be used in the EU food and beverage industry. Europe represents a vast market and we intend to work aggressively to establish European distribution of our Stevia products and work with industry leaders to develop unique products to address the needs of today's consumer seeking healthy, all natural, low calorie sweeteners."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. engages in the areas of essential traditional Chinese medicine and zero calorie natural sweeteners (Sunwin Stevia(TM) Extracts). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit www.sunwininternational.com.
Contact:
Lillian WongU.S. Representative 954-363-7333 ir@sunwininternational.com
Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance and expectations regarding revenues, net income and earnings.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2011.
SOURCE Sunwin International Neutraceuticals, Inc.
www.prnewswire.com
Copyright (C) 2011 PR Newswire. All rights reserved
..."
17:05:24 X 0,34 1000
16:57:41 X 0,336 10000
16:57:31 X 0,337 10000
16:56:34 X 0,339 2500
16:53:47 X 0,339 3000
16:49:21 X 0,336 5000
16:47:43 X 0,34 1000
16:43:36 X 0,337 15000
16:37:55 X 0,341 7000
16:37:00 X 0,342 50000
16:57:41 X 0,336 10000
16:57:31 X 0,337 10000
16:56:34 X 0,339 2500
16:53:47 X 0,339 3000
16:49:21 X 0,336 5000
16:47:43 X 0,34 1000
16:43:36 X 0,337 15000
16:37:55 X 0,341 7000
16:37:00 X 0,342 50000
17:06:30 0,35 50000
12:21:28 0,346 550
08:51:25 0,313 0
08:04:28 0,302 0
Käufer sind nach Hause gekommen......
12:21:28 0,346 550
08:51:25 0,313 0
08:04:28 0,302 0
Käufer sind nach Hause gekommen......
www.prweb.com/releases/2011/11/prweb8963748.htm
bin gespannt auf die restwoche......vor allem vom aktionär erwarte ich eine große beschreibung.
bin gespannt auf die restwoche......vor allem vom aktionär erwarte ich eine große beschreibung.
Wer jetzt schon wieder verkauft, den kann man nicht mehr helfen, sorry. Jetzt kann es doch erst richtig losgehen.
da ist sie ja schon
von-trader-fuer-trader.de/
mal sehen für welche richtung wir uns entscheiden....
aha
von-trader-fuer-trader.de/
bid/ask 0.473 / 0.475
servu$
servu$
app.quotemedia.com/quotetools/...;cp=off&webmasterId=89753
/**/ document.writeln("\n\n\n\n\n\n\n\n
\n\n\n\n\n\n\n\n  \n\n\n\n\n\n\n\n |
\n\n");
www.deaf-deaf.de/?p=190811 hier trifft man einige zielgruppen......
Es gibt keine neuen Beiträge.
|
Neueste Beiträge aus dem Sunwin Stevia International Inc Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
56 | 36.004 | Twimc... | Huelsenbeck1 | Huelsenbeck1 | 15.08.25 15:43 | |
| 21 | 12.292 | Ab hier geht ´s nach oben - Sunwin - Stevia | hammerbuy | Ratu Marika | 28.08.23 21:13 | |
| 2 | 111 | Sunwin | hermann40s | dieterkuhn | 24.02.22 13:19 | |
| 264 | labbert einfach | dieterkuhn | dieterkuhn | 02.10.21 17:00 | ||
| 101 | Sun win A0D9SL | Cincinnati | dieterkuhn | 02.10.21 17:00 |